Tagged with PR

Indonesia Agus Heru Darjono, President Director at Metro Drug Indonesia, highlights the opportunities in the Indonesian Third Party Commercialization sector and emphasizes the importance of building the best team in order to successfully perform in an ever-changing market like Indonesia. Can you briefly speak towards the history as well as the…

Colombia Héctor Castro, director of Medicines and Health Technologies at the Colombian Ministry of Health since 2016, explains how the regulations and quality standards implemented have contributed to make Colombia’s healthcare system one of the best in Latin America. You were appointed director of Medicines and Health Technologies at the Ministry…

Indonesia Endang Hoyaranda, Commissioner and President Director at Prodia Group, elaborates on Prodia’s pioneering spirit when implementing its diversification business strategy and explains how the company has successfully completed its IPO process on the Indonesian stock exchange (IDX). Prodia recently completed its IPO in the Indonesian stock market (IDX) issuing 25…

Taiwan Jassy Wang, CEO of MegaPro Biomedical, a nanomedicine development company specializing in developing nanoparticles and nanomicelles, discusses the evolving nanomedicine market in Taiwan and reveals the company’s plans for future growth. Can you introduce MegaPro Biomedical to our readers? “Nanosize features many advantages; amongst them I would highlight the ability…

Taiwan Eric Tsao, founder of Synermore Biologics, talks about how a company employing 90 people can successfully operate internationally and efficiently progress with its biosimilar and innovative product development pipeline. He also discusses what business strategy and potential partnerships will determine the successful growth of the company in the future. You…

Ukraine Dr. Volodymyr Redko, executive director of Ukraine’s Association of Pharmaceutical Research and Development (APRaD), which gathers together 15 international R&D-driven companies, provides insights into the perspective of international innovators vis-à-vis the numerous regulatory and structural reforms that are set to transform the country’s health system, while highlighting the importance that…

Taiwan Ming-Kuei Jang, founder and CEO of Aprinoia, a very promising Taiwan-based company focused on the development of groundbreaking imaging tracers and therapeutics targeting tau-related neurodegenerative diseases, provides insights into the company’s rapid development over the past two years, its R&D strategy, and its eagerness to partner with both academia and…

Indonesia Dr. Agus Prabowo, chairman at LKPP (the Indonesian National Public Procurement Agency) explains the importance of embracing technology to gain efficiency and effectiveness in the public procurement process of healthcare products as well as the outcomes from e-catalogue implementation in Indonesia. Could you please introduce the main activities of LKPP…

Mexico José Antonio Garcia, CEO of Vensi, describes how the company’s unique service model is redefining how healthcare institutions approach the purchasing of medical equipment, while detailing the strategic significance of the recently award IMSS contract in validating their business model and augmenting future business prospects. Could you please introduce yourself…

Switzerland Despite increasing consolidation in the clinical trial industry, there’s enough market share to go around says SOCAR Research CEO Bridget-Anne Kirwan. For SOCAR Research, it’s the company’s strong academic roots in addition to personalized, tailored and innovative services that have helped to make the difference. To begin, could you please…

Switzerland With more than 20 years of experience working with the Swiss pharmaceutical sector, general manager Roland Laudenbacher explains that Honeywell Building Solutions has developed a true specialization in projects for pharma clients, including their own in house GMP validation services. To begin, could you please introduce Honeywell Business Solutions, and…

Mexico Aimed to ignite a paradigm shift away from the current traditional distributor model, Salumedic’s Managing Director, Gabriel Tagle, shares the novel business concept with zeal and sharp business acumen. He speaks about Saludemic’s core value preposition of being a “commercial hand” to key healthcare players, the crucial importance of proper…